References Gonzalez-Ramirez, P
The approval of semaglutide for MASH highlights the importance of understanding the hepatoprotective mechanisms of GLP-1 action, the investigators stated
A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-I gene mediates the liver-specific induction by thyroid hormone
Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
Effective dose 1000 mg per capsule, a level considered effective in scientific research
Semaglutide is neuroprotective and reduces -synuclein levels in the chronic MPTP mouse model of parkinsons disease